UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause

Expert review of clinical pharmacology, 2019-08, Vol.12 (8), p.729-739

2019

Volltextzugriff (PDF)

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH Phase 3 study design of a combination capsule and evidence review

Maturitas, 2015-11, Vol.82 (3), p.323-324

2015

Volltextzugriff (PDF)

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review

Maturitas, 2015-05, Vol.81 (1), p.28-35

2015

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol

Menopause (New York, N.Y.), 2016-05, Vol.23 (5), p.506

2016

Volltextzugriff (PDF)

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Menopause (New York, N.Y.), 2016-10, Vol.23 (10), p.1075

2016

Volltextzugriff (PDF)

Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries

Post reproductive health, 2016-09, Vol.22 (3), p.112-122

2016

Volltextzugriff (PDF)

Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective

Pharmacy, 2020-08, Vol.8 (3), p.156

2020

Volltextzugriff (PDF)

The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment

Journal of sexual medicine, 2017-03, Vol.14 (3), p.413-424

2017

Volltextzugriff (PDF)

Systemic estradiol levels with low-dose vaginal estrogens

Menopause (New York, N.Y.), 2020-03, Vol.27 (3), p.361

2020

Volltextzugriff (PDF)

Why I started a women's health pharmaceutical company

Contemporary ob/gyn, 2020-09, Vol.65 (9), p.16A-16C

Bernick, Brian A

2020

Volltextzugriff (PDF)

The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate

Journal of sexual medicine, 2017-03, Vol.14 (3), p.425-433

2017

Volltextzugriff (PDF)

A new solubilized vaginal estradiol in a VagiCap™ for the treatment of vaginal atrophy

Maturitas, 2015-11, Vol.82 (3), p.324-324

2015

Volltextzugriff (PDF)

Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion

Expert opinion on drug delivery, 2020-11, Vol.17 (11), p.1573-1581

2020

Volltextzugriff (PDF)

Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women

Menopause (New York, N.Y.), 2019-06, Vol.26 (6), p.622

2019

Volltextzugriff (PDF)

Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10074-10074

2018

Volltextzugriff (PDF)

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

Menopause (New York, N.Y.), 2022-02, Vol.29 (3), p.304

2022

Volltextzugriff (PDF)

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history

Menopause (New York, N.Y.), 2019-02, Vol.26 (2), p.124

2019

Volltextzugriff (PDF)

Endometrial Safety of Low Dose Vaginal Estrogens in Menopausal Women [39P]

Obstetrics and gynecology (New York. 1953), 2018-05, Vol.131 Suppl 1 (1), p.183S-184S

2018

Volltextzugriff (PDF)

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Menopause (New York, N.Y.), 2019-07, Vol.26 (7), p.800

2019

Volltextzugriff (PDF)

Demographics and the Placebo Response in the REPLENISH TRIAL: A Study of Vasomotor Symptoms [16OP]

Obstetrics and gynecology (New York. 1953), 2018-05, Vol.131 Suppl 1 (1), p.6S-6S

2018

Volltextzugriff (PDF)

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

Menopause (New York, N.Y.), 2020-09, Vol.28 (1), p.32

2020

Volltextzugriff (PDF)

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INHIBITION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Fertility and sterility, 2021-09, Vol.116 (3), p.e48-e48

2021

Volltextzugriff (PDF)

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INDUCTION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Fertility and sterility, 2021-09, Vol.116 (3), p.e47-e47

2021

Volltextzugriff (PDF)

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms

Menopause (New York, N.Y.), 2019-05, Vol.26 (5), p.506

2019

Volltextzugriff (PDF)

Effects of Estradiol Dose and Serum Estradiol Levels on Metabolic Measures in Early and Late Postmenopausal Women in the REPLENISH Trial

Journal of women's health (Larchmont, N.Y. 2002), 2020-08, Vol.29 (8), p.1052

2020

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(89)
Reviews
(1)

Sprache

Englisch
(90)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(46)
Female
(45)
Life Sciences & Biomedicine
(45)
Middle Aged
(31)
Obstetrics & Gynecology
(28)
Aged
(27)
Menopause
(26)
Estradiol
(24)
Double-Blind Method
(19)
Postmenopause
(19)
Adult
(18)
Estradiol - Administration & Dosage
(17)
Original
(16)
Progesterone
(16)
Administration, Intravaginal
(14)
Treatment Outcome
(14)
Vagina - Pathology
(12)
Male
(11)
Dyspareunia - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH Phase 3 study design of a combination capsule and evidence review

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review

A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries

Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective

The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment

Systemic estradiol levels with low-dose vaginal estrogens

Why I started a women's health pharmaceutical company

The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate

A new solubilized vaginal estradiol in a VagiCap™ for the treatment of vaginal atrophy

Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion

Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women

Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history

Endometrial Safety of Low Dose Vaginal Estrogens in Menopausal Women [39P]

Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review

Demographics and the Placebo Response in the REPLENISH TRIAL: A Study of Vasomotor Symptoms [16OP]

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INHIBITION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INDUCTION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms

Effects of Estradiol Dose and Serum Estradiol Levels on Metabolic Measures in Early and Late Postmenopausal Women in the REPLENISH Trial

Suchergebnisse filtern